Roundtable Discussion
Time: 4:40 pm
day: Conference Day One
Details:
- Understanding the Relationship between the various retinal imaging biomarkers with disease progression
- Challenges associated with the interpretation of imaging data – do they demonstrate drug safety and efficacy?
- How can AI be used to further refine knowledge from retinal imaging? Discussing the role of AI in drug target identification, safety and efficacy assessment
Moderator Feedback & Audience Debate:
Moderators will be assigned to each roundtable to facilitate discussion and collate the findings. Following the roundtable discussions, they will present back to the entire delegation and open up wider audience debate.
